“I am convinced that what we lack today to confirm the value creation potential of the industrial biotechnology are concrete examples of investments to construct real industrial operations that are profitable and that create manufacturing jobs.
So all national and European initiatives – co-investment, easing of regulatory procedures, tax incentives, etc. – that will facilitate risk-taking in the industrial phase will be welcomed to demonstrate the industrial biotechnology’s potential and accelerate its development”. To say it – in this interview with Il Bioeconomista – is Benjamin Gonzalez, founder and CEO of METabolic EXplorer, a French green chemistry company that develops and patents innovative, fermentation-based industrial processes. Waiting for EFIB, the European Forum for Industrial Biotechnology and the Bioeconomy – which will take place next October 27-29 in Brussels – Il Bioeconomista will host a series of interviews with CEOs, who will be guest speakers in Brussels. Today we offer the second, after the first with Ilkka Hämälä, CEO of Metsä Fibre, published last 21 August.
Interview by Mario Bonaccorso